Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

NCT06100705 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: Testosterone Cypionate
DRUG: Sipuleucel-T

Sponsor

Yale University

Collaborators

[object Object]